Pioneer the path toward precision oncology—from preclinical to companion diagnostic development

The discovery of genetic biomarkers and their subsequent application in oncology research are paving the path to targeted therapy development and selection, linking genes to disease states and prognosis and, ultimately, more effective treatments. Learn how our targeted next-generation sequencing panel and workflow, as well as our expertly curated bioinformatics database and services, help deliver powerful solutions for drug and companion diagnostic development.

Learn more from a member of our clinical research team:

Contact us

oncominefocus

Oncomine™ Focus Assay

The Oncomine™ Focus Assay is a multi-biomarker next-generation sequencing oncology assay designed to analyze 52 genes relevant to solid tumors. This assay enables concurrent analysis of DNA and RNA in a single workflow, and requires minimal starting FFPE-extracted nucleic acid material to detect hotspots, SNVs, indels, CNVs, and gene fusions. Designed for translational and clinical research, this assay includes genes targeted by on-market oncology drugs and published evidence.

file

Oncomine™ Comprehensive Assay

The Oncomine™ Comprehensive Assay* is a multi-biomarker next-generation sequencing assay that provides analysis of 143 genes relevant to clinical trials and investigational drug targets as well as published evidence.  This assay enables concurrent analysis of DNA and RNA in one workflow, and requires minimal starting FFPE-extracted nucleic acid material.  This assay is designed to provide a comprehensive view of the most common mutations and those under investigation.

file

Compendia Bioscience™ Bioinformatics Services

The Compendia Bioscience™ Bioinformatics Services team of highly experienced, PhD-level scientists is ready to help you apply cancer informatics to the drug discovery and development continuum. Learn about how our team of translational bioinformatics experts can harness cancer genomic data and computational biology to help transform your oncology drug development efforts.

*For Research Use Only. Not for use in diagnostic procedures.

In the news

Events/Webinars